Top brokerages on stocks today, August 6: Bharti Airtel, Adani Ports, Britannia, DLF, Gland Pharma & more in focus

Leading brokerages have issued fresh views on select Indian stocks following Q1 results and recent developments. Here's a roundup of key commentary from analysts:

Bharti Airtel share: Macquarie, CLSA, Citi maintain outperform, MS retains equal-weight

Macquarie: Maintains Outperform; TP ₹2,050. Strong ARPU gain, capex control, and record free cash flow.

CLSA: Maintains Outperform; TP ₹2,035. Strong YoY growth in mobile revenue and EBITDA; record subscriber additions.

Citi: Maintains Buy; TP ₹2,250. Strong Q1 aided by lower capex and higher free cash flow; homes segment performance robust.

Morgan Stanley: Maintains Equal-weight; TP ₹1,890. India business EBITDA beat expectations; ARPU at ₹250.

Adani Ports share: Jefferies, GS, CLSA, Bernstein bullish with raised targets

Jefferies: Maintains Buy; TP raised to ₹1,815. Volume growth driven by new ports and margin expansion.

Goldman Sachs: Maintains Buy; TP raised to ₹1,510. Strong portfolio and improving balance sheet.

CLSA: Maintains Outperform; TP ₹1,764. Robust guidance; 1Q traffic up 11% YoY, PAT up 26% YoY.

Bernstein: Maintains Outperform; TP ₹1,617. EBITDA beat led by new business additions.

Gland Pharma share: Jefferies upgrades, GS remains cautious

Jefferies: Upgrades to Hold from Underperform; TP raised to ₹1,950. Cenexi breakeven supports margin recovery.

Goldman Sachs: Maintains Sell; TP ₹1,675. Broadly in line; weak US performance offsets Cenexi strength.

Berger Paints share: MS bearish, Nuvama remains positive

Morgan Stanley: Underweight; TP ₹482. Marginal revenue growth; continued market share gains.

Nuvama: Maintains Buy; TP raised to ₹670. Gradual demand recovery expected in H2FY26.

Britannia share: Mixed views across brokerages

Macquarie: Maintains Underperform; TP ₹4,850. EBITDA miss and tough competitive environment.

Nomura: Neutral; TP ₹5,875. Volumes and gross margins below forecast.

Morgan Stanley: Maintains Equal-weight; TP ₹5,511. Weakest EBITDA margin in 11 quarters.

DLF share: Jefferies, BoFA remain bullish

Jefferies: Maintains Buy; TP ₹1,000. Strong pre-sales and confidence in FY26 targets.

BoFA Securities: Maintains Buy; TP ₹945. Robust start with Mumbai project success.

Aegis Vopak share: Jefferies initiates Hold

Jefferies: Initiates Hold; TP ₹270. Long-term play on India’s LPG demand; valuations stretched.

Gujarat Fluorochemicals share: UBS maintains sell

UBS: Maintains Sell; TP ₹3,000. Margins improved but EV business contribution to remain gradual.

Gujarat Gas share: Citi cautious

Citi: Maintains Sell; TP ₹410. Q1 miss on both volume and margin; stock appears expensive.

Bosch share: UBS cautious despite TP hike

UBS: Maintains Sell; TP raised to ₹26,900. Valuations stretched post recent rally.

Aurobindo Pharma share: Avendus trims target, retains reduce

Avendus: Maintains Reduce; TP cut to ₹1,145. EPS estimates downgraded due to margin concerns.

Lupin share: Nomura positive

Nomura: Maintains Buy; TP ₹2,350. PAT beat estimates; India and US business performing well.

Concor share: MS bearish

Morgan Stanley: Underweight; TP ₹515. Revenue and margin performance below estimates.

Bharti Hexacom share: CLSA downgrades

CLSA: Downgrades to Underperform; TP ₹1,525. Revenue miss; broadband additions encouraging.

Bandhan Bank share: Kotak Inst. remains optimistic

Kotak Institutional Equities: Maintains Buy; TP ₹225. Management focused on deposit portfolio and new business investments.

Exide Industries share: MOSL neutral

Motilal Oswal: Maintains Neutral; TP ₹379. Margin gains noted; lithium-ion venture promising but cautiously viewed.

Torrent Power share: Avendus cuts TP

Avendus: Maintains Add; TP cut to ₹1,500. Estimates lowered post weak Q1; growth outlook intact.

Alembic Pharma share: Antique bullish

Antique: Maintains Buy; TP raised to ₹1,275. US launches in Q2 expected to drive near-term growth.

Navin Fluorine share: MOSL neutral

Motilal Oswal: Maintains Neutral; TP ₹5,100. CDMO and advanced materials to drive long-term growth.

Cement sector: CLSA sees price support despite weak demand

CLSA: Prices holding up amid monsoon; 6-7% FY26 growth likely. Prefer UltraTech and Ambuja among peers.

Disclaimer: The views and investment suggestions expressed by brokerages are their own and do not represent the views of this publication. This article is purely for informational purposes and is not a recommendation in any form.